Unger, Ketterer, Dupr, Eisentraut
AnnualSave 47% Discounted annual rate Access to all articles (web + app) Ad-free exclusive newsletters Commenting Access Daily crossword Sneak peek of launches & events Monthly Access to all articles (web + app) Ad-free exclusive newsletters Commenting Access Daily crossword Sneak peek of launches & events Ad-Free Premium ad-free reading Access to all articles (web + app) Ad-free exclusive newsletters Commenting Access Daily crossword Sneak peek of launches & events Looks like you already have a subscription
Your doctor may also want to double-check whether the GLP-1 medication is really the cause of your diarrhea
This body of evidence, given its generation largely in small animal- and cell culture-based models, is suggestive, but not sufficient
They were initially aimed at treating patients with type 2 diabetes, but some are now developed specifically to treat obesity
The researchers found that when participants took semaglutide, they saw the following improvements: 42 percent lower risk of psychiatric-related hospital care and sick leave 44 percent lower risk of worsening or new depression 38 percent lower risk of worsening or new anxiety 47 percent lower risk of substance use disorder diagnosis or treatment Other GLP-1 drugs showed more variable effects: Liraglutide was linked to a lower risk of worsening depression but not anxiety